-
preprints
2025
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2024
置信度 0.74
-
preprints
2024
置信度 0.74
-
preprints
2026
置信度 0.74
-
preprints
2024
置信度 0.74
-
preprints
2024
置信度 0.74
-
preprints
2024
置信度 0.74
-
preprints
2024
置信度 0.74
-
preprints
2024
置信度 0.74
-
preprints
2024
置信度 0.74
-
preprints
2024
置信度 0.74
-
preprints
2025
置信度 0.74
-
preprints
2024
置信度 0.74
-
Performing effective gene-editing experiments requires a deep understanding of both the CRISPR technology and the biological system involved. Meanwhile, despite their versatility and promise, Large Language Models (LLMs) often lack domain-specific knowledge an…
preprints
2024
置信度 0.74
-
crossref
Oseias R. Feitosa-Junior
2026-08-28T13:27:27Z
置信度 0.70
-
crossref
2019-07-08T16:00:39Z
置信度 0.70
-
crossref
2024-03-18T08:02:35Z
置信度 0.70
-
crossref
2018-04-19T02:01:55Z
置信度 0.70
-
crossref
Clare Wilson
2024-03-29T20:09:48Z
置信度 0.70
-
crossref
Stephen Chrzanowski, Ranjan Batra
2024-02-01T21:57:21Z
置信度 0.70
-
crossref
Neha Thakur, Hiralben Lakhani, Siddharth Tiwari
2024-03-18T08:02:35Z
置信度 0.70
-
crossref
Tejaswini Kumawat, Aditi Agarwal, Sonika Saxena, Sudipti Arora
2024-03-18T08:02:35Z
置信度 0.70
-
crossref
N. Türkölmez, G.Ç. Kılıç, N. Arslan, Y. Özden-Çiftçi
2024-03-22T09:24:05Z
置信度 0.70
-
crossref
2016-10-25T07:35:06Z
置信度 0.70
-
The potential for significant advancements in disease management is highlighted by this review, which looks at the application of CRISPR gene editing for treating allergies, particularly those related to allergens. It also evaluates the benefits and limitation…
crossref
Digvijay Singh, Mohammed Ismail Iqbal
2025-08-12T10:18:07Z
置信度 0.70
-
crossref
Weimin Tang
2024-08-29T06:31:02Z
置信度 0.70
-
In recent years, gene editing technology has made breakthrough progress. This article uses Cre-loxP and CRISPR-Cas9 as examples to explore its application prospects in the agricultural field. Current research has made substantial progress in using these techno…
crossref
Rou Duan
2024-06-06T15:51:03Z
置信度 0.70
-
crossref
Surender Singh, Roni Chaudhary, Siddhant Chaturvedi, Siddharth Tiwari
2024-03-18T08:02:35Z
置信度 0.70
-
Safety considerations for gene therapies of inherited preleukemia syndromes, including severe congenital neutropenia (CN), are paramount. We compared several strategies for CRISPR/Cas9 gene editing of autosomal-dominant ELANE mutations in CD34 + cells from two…
crossref
Malte Ulrich Ritter, Masoud Nasri, Benjamin Dannenmann, Perihan Mir 等
2024-10-22T10:00:21Z
置信度 0.70
-
crossref
Sean T Campbell
2024-10-03T13:24:12Z
置信度 0.70
-
The Biochemical Society identifies and celebrates outstanding science communication talent in molecular biosciences with its annual Science Communication Prize. Cansu Kizilkaya, from Turkey, won the second prize in the written category for students studying fo…
crossref
Cansu Kizilkaya
2024-02-02T11:52:21Z
置信度 0.70
-
crossref
Natalie Healey
2024-08-05T15:03:41Z
置信度 0.70
-
crossref
Sakshi Patel, Ameeta Sharma, Neha Batra, Ronak Chetani 等
2024-03-18T08:02:35Z
置信度 0.70
-
crossref
2019-06-25T13:25:55Z
置信度 0.70
-
crossref
Chihan Wang
2024-01-08T23:55:13Z
置信度 0.70
-
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is a surface receptor expressed in macrophages during tissue injury. This receptor plays a role in driving phagocytosis and dampening inflammation. Because of this, it plays a large part in diseases such…
crossref
Mohnish Alishala
2024-03-03T22:36:47Z
置信度 0.70
-
Clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing has begun to transform the treatment landscape of genetic diseases. The history of the discovery of CRISPR/CRISPR-associated (Cas) proteins/single-guide RNA (sgRNA)-based gen…
crossref
Rina Kansal
2024-07-03T06:04:18Z
置信度 0.70
-
crossref
ZahraSadat Razavi, Madjid Soltani, Mohammad Souri, Andre J. van Wijnen
2024-10-18T05:11:10Z
置信度 0.70
-
crossref
Siddhi Parab, Shalini Tiwari, Sivasubramanian Rajarammohan, Sneh Lata Singla-Pareek 等
2024-03-18T08:02:35Z
置信度 0.70
-
CRISPR-Cas9 is a gene editing tool used extensively in biological research that is now making its way into clinical therapies. With the first CRISPR therapy obtaining approval by the United States’ Food and Drug Administration (FDA) in late 2023, we look at cl…
europepmc
Aditya Bharti, Joann Mudge
2025
置信度 0.80
-
Gene editing technologies have revolutionized the field of genetic disease therapy and research. Among these, CRISPR/Cas9 stands out as a versatile tool for precisely targeting and modifying specific sequences within the genome. This paper provides an overview…
crossref
Sanjay Singh
2024-06-30T17:45:05Z
置信度 0.70
-
crossref
Indu Singh Sankhla, Anil Kumar, Chandra Pal Singh
2024-03-18T08:02:35Z
置信度 0.70
-
crossref
Nikhil Deep Kolanu
2024-03-29T19:36:48Z
置信度 0.70
-
The invention of next-generation CRISPR/Cas gene editing tools, like base and prime editing, for correction of gene variants causing disease, has created hope for in vivo use in patients leading to wider clinical translation. To realize this potential, deliver…
crossref
Jacob Hørlück Janns, Jacob Giehm Mikkelsen
2024-08-16T07:26:51Z
置信度 0.70
-
crossref
Yanlin Wang, Qiqi Zhou, Jia Chen
2025-07-11T08:53:36Z
置信度 0.70
-
crossref
Qiming Cheng
2024-01-08T23:53:06Z
置信度 0.70
-
crossref
2020-04-07T08:48:17Z
置信度 0.70
-
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder. It triggers metabolic disorders within the body due to genetic mutations, thus leading to irreversible damage to one's memory and brain. The primary pathogenic features of AD are intracellular…
crossref
Xiangjun Zhang
2024-10-14T03:06:28Z
置信度 0.70
-
crossref
2020-04-07T08:48:17Z
置信度 0.70
-
crossref
2020-04-07T08:48:17Z
置信度 0.70
-
The CRISPR-Cas9 system has been applied for clinical applications of gene therapy. Most CRISPR-based gene therapies are derived from Streptococcus pyogenes Cas9, which is challenging to package into a single adeno-associated virus vector and limits its clinica…
crossref
Siyuan Liu, Yingdi Zhao, Qiqin Mo, Yadong Sun 等
2024-11-18T11:13:28Z
置信度 0.70
-
crossref
2026-04-23T21:11:07Z
置信度 0.70
-
crossref
Shiu-Wan Chan
2024-06-21T13:00:43Z
置信度 0.70
-
crossref
Khushal Khambhati, Gargi Bhattacharjee, Vijai Singh
2024-11-19T12:10:48Z
置信度 0.70
-
In "genome editing," a type of genetic engineering, DNA is added, taken away, or changed in an organism's genome. Biomedicine, biotechnology, and synthetic biology, just to name a few, have all gained a lot from how often this method is used. Before the editin…
crossref
Dr. Taha Nazir, Hameed A. Mirza, Sahar Radwan, Nida Taha
2024-01-30T03:09:42Z
置信度 0.70
-
crossref
Biswajit Pramanik, Sandip Debnath, Anamika Das
2024-03-05T19:34:56Z
置信度 0.70
-
As global warming increases, mosquito activity areas are expanding, alongside changes in the natural environment and the misuse of insecticides, thus further increasing mosquito resistance and exposing the world to an elevated risk of mosquito-borne diseases. …
crossref
Xiaohui Liu, Xinyu Zhou, Xiaoxue Xie, Chunxiao Li
2024-09-20T23:10:17Z
置信度 0.70
-
Plastics used in people's daily life bring convenience on the one hand, and on the other hand, a large amount of plastic waste also brings great pollution to the environment. Polyethylene terephthalate (PET) is a polymer polymerization material, which has beco…
crossref
Jingtong Liu, Ke Wu
2024-06-18T18:02:36Z
置信度 0.70
-
Gene editing technologies have revolutionized the field of genetics, offering unprecedented precision in modifying DNA sequences. This article explores the evolution of gene editing technologies, focusing on CRISPR-Cas9, the most transformative advancement in …
crossref
Dr. Fatima Tariq
2026-04-17T08:10:41Z
置信度 0.70
-
Abstract The CRISPR/Cas nucleases system is widely considered the most important tool in genome engineering. However, current methods for predicting on/off-target effects and designing guide RNA (gRNA) rely on purely data-driven approaches or focus solely on t…
crossref
Lei Jin, Risi Liyanage, Dongsheng Duan, Shi-Jie Chen
2024-05-02T13:35:21Z
置信度 0.70
-
Clustered regularly interspaced short palindromic repeats (CRISPR) based gene-editing has begun to transform the treatment landscape of genetic diseases. The history of the discovery of CRISPR/CRISPR-associated (Cas) proteins/single guide RNA (sgRNA)-based gen…
preprints
Rina Kansal
2024
置信度 0.74
-
crossref
Gail Dutton
2019-05-29T09:44:09Z
置信度 0.70
-
crossref
Chen Liang, Yi Lu, Rudi Mai
2024-11-15T06:07:33Z
置信度 0.70
-
Transthyretin amyloid cardiomyopathy is a fataldisease of the myocardium causing a protein buildup of Transthyretin. Over 120,000 people in the United States suffer from transthyretin amyloid cardiomyopathy, and half of those diagnosed will die within four yea…
crossref
Caden L. Reedy
2025-01-30T11:00:16Z
置信度 0.70
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Precision genome editing, particularly using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), is advancing crop improvement by enabling targeted and efficient genetic modifications. Root and tuber crops suc…
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
The CRISPR-Cas system has evolved into a highly efficient platform for genome editing and programmable gene regulation, demonstrating broad application potential in microbiology, biotechnology, and medicine. However, traditional CRISPR tools typically rely on …
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
The convergence of nanotechnology and genome editing in plant sciences is redefining modern precision breeding through efficient, transgene free, tissue culture independent pathways for genetic improvement in crops. Conventional breeding and transgenic tools a…
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
crossref
2017-02-27T18:55:12Z
置信度 0.70
-
Purpose: The purpose of this dissertation is to investigate the feasibility of using tests of robustness in peer review. This study involved selecting three high-impact papers which featured open data and utilized bioinformatic analyses but provided no source …
datacite
Leipzig,Jeremy
2021
置信度 0.66
BioinformaticsMetadataPeer reviewReproducibilityReproducible research
-
Abstract Proso millet (Panicum miliaceum L.) is among the earliest domesticated millet species and serves as a vital staple food for populations living in arid and semi-arid regions worldwide. This review highlights its rich nutritional profile, including high…
datacite
Tahere Razzaghi1, Fatemeh Naderi2, Maryam Salami1,3*, Gholamreza Askari4, Najmeh Salehi5
2025
置信度 0.66